[
  {
    "ts": "2025-07-28T10:57:00+00:00",
    "headline": "Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel",
    "summary": "The Global Cell and Gene Therapy Third-Party Logistics Market is projected to surge to US$ 20.98 billion by 2033, up from US$ 8.66 billion in 2024, growing at a CAGR of 10.33%. Key growth drivers include technological advancements in cold chain logistics, an increase in clinical studies, and the rise of personalized medicine. The expanding demand for cell and gene therapies necessitates temperature-sensitive logistics solutions. Major players like Cardinal Health and McKesson Corporation are enh",
    "url": "https://finance.yahoo.com/news/cell-gene-therapy-third-party-105700654.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "bb7beff3-3cf4-3aae-81a0-727760839d37",
      "content": {
        "id": "bb7beff3-3cf4-3aae-81a0-727760839d37",
        "contentType": "STORY",
        "title": "Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel",
        "description": "",
        "summary": "The Global Cell and Gene Therapy Third-Party Logistics Market is projected to surge to US$ 20.98 billion by 2033, up from US$ 8.66 billion in 2024, growing at a CAGR of 10.33%. Key growth drivers include technological advancements in cold chain logistics, an increase in clinical studies, and the rise of personalized medicine. The expanding demand for cell and gene therapies necessitates temperature-sensitive logistics solutions. Major players like Cardinal Health and McKesson Corporation are enh",
        "pubDate": "2025-07-28T10:57:00Z",
        "displayTime": "2025-07-28T10:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/0e16d886360cd133e42c3adf0151d742",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Cell and Gene Therapy Third-Party Logistics Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5eXH6NVXBJG26Vlfd9IWTg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e16d886360cd133e42c3adf0151d742.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ReKp2IQCqNv3dhft1JIh.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e16d886360cd133e42c3adf0151d742.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cell-gene-therapy-third-party-105700654.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cell-gene-therapy-third-party-105700654.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            },
            {
              "symbol": "MCK"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "DHL.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]